Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06695065

Value of Speckle Tracking Echocardiography Inflammatory Bowel Disease Patients

Value of speckle tracking echocardiography in early assessment of cardiac function in inflammatory bowel disease .

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Observational

About this study

Ulcerative colitis (UC) is a common form of inflammatory bowel disease (IBD) that consists of chronic inflammatory disorders of the colon and the small intestine with unknown etiology. Chronic inflammation is the basis of complicated pathogenesis, and the course of the disease is often complicated by an immune response. Malnutrition, malabsorption and the involvement of organs other than those of the gastrointestinal tract are frequent consequences of the disease . Although extra-intestinal manifestations of IBD are common (ranging from 6% to 47%), cardiac involvement is rare.

Inflammatory bowel disease (IBD) is a known risk factor for cardiovascular disease (CVD). IBD patients have a two- to threefold increased risk of venous thromboembolism, particularly during acute flares when disrupted homeostasis of anti- and procoagulants leads to a hypofibrinolytic state. Cardiovascular manifestations in Crohn's disease (CD) and ulcerative colitis (UC) include conditions such as Takayasu's arteritis, pericarditis, and myocarditis. Chronic inflammation and altered lipid metabolism, along with long-term use of anti-inflammatory drugs (e.g., corticosteroids, TNF-α inhibitors), are thought to drive CV pathology in IBD. Additionally, chronic inflammation is linked to pathological collagen deposition in affected organs.

Although conventional echocardiography is a widely accessible and easy tool to detect cardiac abnormalities, novel echocardiographic techniques and indices offer easy, reproducible and quantitative information for evaluating left ventricle function and subclinical changes . Speckle tracking echocardiography (STE) is an advanced echocardiographic methodology for the quantification of myocardial function. STE has been successfully used to identify early subclinical cardiac involvement in a variety of asymptomatic populations with chronic diseases and unremarkable conventional echocardiography. Unlike earlier echocardiography techniques, two-dimensional speckle tracking echocardiography (2DSTE) is less angle-dependent. In addition, STE is not affected by the rotation of the heart and allows heart functions to be examined segment by segment from various echocardiographic views . Despite, studies have examined subclinical cardiac impairment in patients with IBD, to the best of our knowledge, none have explored the impact of ulcerative colitis activity on cardiac function through using STE.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age (18-60) yrs.
  • Both sexes.
  • Patients with IBD either in active form or in remission.

Exclusion criteria

  • Patients with ischemic heart disease. -Patients with other comorbidities affecting heart as uncontrolled hypertension or diabetes. -
  • Pregnant females.
  • Malignancy

Treatment and study plan

Primary outcomes

  1. Subclincal cardiovascular events in IBD patients.

    Time frame: through study completion, an average of 2 year

    Assessment the predictive ability of Speckle TRACKING Echocardiograpy in development of subclinical cardiovascular events in IBD patients.

  2. Relation between isease activity and cardiac function

    Time frame: through study completion, an average of 2 year

    Evaluation of the relationship between disease activity and cardiac function as measured by Speckle tracking Echocardiograpy.

Secondary outcomes

  1. correlation of Speckle TRACKING Echocardiograpy findings with traditional echocardiographic parameters

    Time frame: through study completion, an average of 1 year

    Detection of correlation of Speckle TRACKING Echocardiograpy findings with traditional echocardiographic parameters and inflammatory markers.

Study contacts

Contact information is provided by the study sponsor or research team.

Asmaa Abdelshafy Mohamed

CONTACT

[email protected]

0109950131

Noor el_deen Abdelazeem Mohamed

CONTACT

[email protected]

0100503518

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Value of Speckle Tracking Echocardiography in Early Assessment of Cardiac Function in Inflammatory Bowel Disease Patients

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Nov 19, 2024
Registry last updated
Oct 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.